194 related articles for article (PubMed ID: 6289301)
1. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.
Neuwelt EA; Barnett PA; Bigner DD; Frenkel EP
Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4420-3. PubMed ID: 6289301
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery.
Neuwelt EA; Barnett PA; Frenkel EP
Neurosurgery; 1984 Feb; 14(2):154-60. PubMed ID: 6200798
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
4. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
Kroll RA; Pagel MA; Muldoon LL; Roman-Goldstein S; Fiamengo SA; Neuwelt EA
Neurosurgery; 1998 Oct; 43(4):879-86; discussion 886-9. PubMed ID: 9766316
[TBL] [Abstract][Full Text] [Related]
5. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
7. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry.
Adam JF; Biston MC; Joubert A; Charvet AM; Le Bas JF; Estève F; Elleaume H
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1173-82. PubMed ID: 15752899
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.
Neuwelt EA; Diehl JT; Vu LH; Hill SA; Michael AJ; Frenkel EP
Ann Intern Med; 1981 Apr; 94(4 pt 1):449-54. PubMed ID: 6782926
[TBL] [Abstract][Full Text] [Related]
9. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.
Neuwelt EA; Maravilla KR; Frenkel EP; Rapaport SI; Hill SA; Barnett PA
J Clin Invest; 1979 Aug; 64(2):684-8. PubMed ID: 457877
[TBL] [Abstract][Full Text] [Related]
10. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Dean RL; Emerich DF; Hasler BP; Bartus RT
Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
[TBL] [Abstract][Full Text] [Related]
11. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
12. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
[TBL] [Abstract][Full Text] [Related]
13. Osmotic opening of the blood-brain barrier to methotrexate in the rat.
Ohno K; Fredericks WR; Rapoport SI
Surg Neurol; 1979 Oct; 12(4):323-8. PubMed ID: 524251
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.
Neuwelt EA; Howieson J; Frenkel EP; Specht HD; Weigel R; Buchan CG; Hill SA
Neurosurgery; 1986 Oct; 19(4):573-82. PubMed ID: 3097567
[TBL] [Abstract][Full Text] [Related]
15. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog.
Neuwelt EA; Frenkel EP; Rapoport S; Barnett P
Neurosurgery; 1980 Jul; 7(1):36-43. PubMed ID: 6774280
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
Cosolo W; Christophidis N
Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195
[TBL] [Abstract][Full Text] [Related]
17. The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas.
Warnke PC; Blasberg RG; Groothuis DR
Ann Neurol; 1987 Sep; 22(3):300-5. PubMed ID: 3118762
[TBL] [Abstract][Full Text] [Related]
18. Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening.
Neuwelt EA; Hill SA; Frenkel EP
Neurosurgery; 1984 Sep; 15(3):362-6. PubMed ID: 6090973
[TBL] [Abstract][Full Text] [Related]
19. The effect of steroids on gentamicin delivery to brain after blood-brain barrier disruption.
Neuwelt EA; Horaczek A; Pagel MA
J Neurosurg; 1990 Jan; 72(1):123-6. PubMed ID: 2294171
[TBL] [Abstract][Full Text] [Related]
20. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
